Patients at risk of recurrent blood clots can now be offered an alternative to warfarin, which some patients find inconvenient due to the need for careful monitoring and regular visits to clinics for blood tests.
According to the latest guidance from NICE, patients can now be offered dabigatran etexilate to prevent recurring DVT and pulmonary embolism in adults.
Howorth’s expertise in engineering clean air is fundamental to the success of the company in providing world class containment, infection control, clean room, air filtration and ventilation systems, serving the global healthcare, life science and wider industrial markets.
Hilton, Belfast
6th June 2025
Coventry Building Society Arena, UK
25th - 26th June 2025
University of Warwick
8th - 9th August 2025
Stansted Radisson Blu
23rd September 2025
Brighton Centre, UK
29th - 30th September 2025
EICC, Edinburgh
16th - 18th November 2025
